|
Thursday 25 November 2004
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Siobhain McDonagh | | Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
The Influence of the Pharmaceutical Industry: Ms Melinda Letts, Chair, Committee on Safety of Medicines Working Group on Patient Information, Paul Flynn MP, Chairman, Commons All-Party Group on Rheumatoid Arthritis, Mr Phil Woolas MP, Trustee, Beat the Benzos Campaign and Mr Cliff Prior, Rethink Severe Mental Illness, were examined.
Mr Jim Thomson, Chief Executive, Depression Alliance, Mr Glynn McDonald, Head, Policy and Campaigns, MS Society, Ms Helen Wallace, Deputy Director, GeneWatch UK and Ms Jenny Hirst, Co-Chairman, Insulin-Dependent Diabetes Trust, were examined.
[Adjourned till Thursday 2 December at Ten o'clock.
Thursday 2 December 2004
Members present:
Mr David Hinchliffe, in the Chair
Mr David Amess
John Austin
Mr Keith Bradley
Mr Simon Burns
Mrs Patsy Calton | | Jim Dowd
Siobhain McDonagh
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
The Influence of the Pharmaceutical Industry: Sir Richard Sykes, Rector, Imperial College London, Professor Patrick Vallance, Professor, Head, Medicine Division, University College London and Sir Iain Chalmers, Editor, The James Lind Library, were examined.
Dr Roberto Solari, Chief Executive Officer, MRC Technology, Medical Research Council, Dr Malcolm Boyce, Chairman, Association for Human Pharmacology in the Pharmaceutical Industry and Mr Harpal Kumar, Chief Executive Officer, Cancer Research Technology, were examined.
[Adjourned till Wednesday 8 December at half past Nine o'clock.
Wednesday 8 December 2004
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Mr Simon Burns
Mrs Patsy Calton | | Mr Jon Owen Jones
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Ordered, That the Committee do send for papers from the following pharmaceutical companies in connection with its inquiry into The Influence of the Pharmaceutical Industry: AstraZenaca, Eli Lilly and Company Limited, GlaxoSmithKline, Pfizer Limited and Wyeth.—(The Chairman.)
Ordered, That the Committee do send for papers from Medicines and Healthcare products Regulatory Agency (MHRA).—(The Chairman.)
Ordered, That the Committee do send for certain papers from market research companies relating to the market for pharmaceutical products.—(The Chairman.)
Public Expenditure 2004: Rt Hon Dr John Reid MP, Secretary of State for Health, Mr John Bacon, Group Director, Health and Social Care Delivery, and Mr Richard Douglas, Director, Finance and Investment, Department of Health, were further examined.
[Adjourned till Thursday 9 December at Ten o'clock.
Thursday 9 December 2004
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Mr Simon Burns | | Mrs Patsy Calton
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
The Prevention of Venous Thromboembolism in Hospitalised Patients: Mrs Linda de Cossart, Consultant Vascular and General Surgeon, Royal College of Surgeons of England, Mr David Warwick, Orthopaedic Surgeon, Southampton University NHS Trust, Professor Ajay Kakkar, Surgical Science and Consultant Surgeon, Barts and the London Medical School, Dr David Keeling, Consultant Haematologist, Oxford Haemophilia Centre and Dr Beverley Hunt, Medical Director, Lifeblood, were examined.
Dr Roger Boyle, National Director, Heart Disease, Department of Health, Professor Sir Michael Rawlins, Chairman, Professor David Barnett, Chairman, Appraisals Committee, National Institute of Clinical Excellence and Professor David Cousins, Head, Safe Medication Practice, National Patient Safety Agency, were examined.
[Adjourned till Thursday 16 December at Ten o'clock.
Thursday 16 December 2004
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mrs Patsy Calton
Jim Dowd | | Mr Jon Owen Jones
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Ordered, That Professor Andrew Webster be appointed a Specialist Adviser to assist the Committee in its inquiry into The Use of New Medical Technologies within the NHS.—(The Chairman.)
Ordered, That Professor Gerard Hastings be appointed a Specialist Adviser to assist the Committee in its inquiry into The Influence of the Pharmaceutical Industry.—(The Chairman.)
Ordered, That Professor Philip James and Professor Martin Jarvis be appointed as Specialist Advisers to assist the Committee in its inquiry into the Public Health White Paper (Cm 6374).—(The Chairman.)
Resolved, That subject to its right to publish any evidence it receives, the Committee, in principle, treat as confidential the papers sent for from pharmaceutical companies under the Order of the Committee [8 December 2004].
The Influence of the Pharmaceutical Industry: Ms Margot James, European President, Ogilvy Healthworld, Mr Mike Paling, Managing Director, Paling Walters, Dr Richard Horton, Editor, The Lancet, Ms Jenny Hope, Medical Correspondent, Daily Mail and Ms Lois Rogers, Medical Editor, Sunday Times, were examined.
[Adjourned till Thursday 13 January 2005 at Ten o'clock.
Thursday 13 January 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Mr Simon Burns
Mr John Owen Jones
| | Siobhain McDonagh
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
In the absence of the Chairman John Austin was called to the Chair.
Ordered, That Professor Griffith Edwards be appointed a Specialist Adviser to assist the Committee in its inquiry into the Public Health White Paper [Cm 6374].—(The Chairman.)
Resolved, That the Committee do visit University College Hospital, London in connection with its inquiry into the Influence of the Pharmaceutical Industry].—(The Chairman.)
The Influence of the Pharmaceutical Industry: Mr Eddie Gray, Senior Vice President and General Manager, and Dr Stuart Dollow, Vice President, Medical Division, GlaxoSmithKline (UK), Mr Chris Brinsmead, Marketing Co-President, and Dr John Patterson, Executive Vice President, Product Strategy, Licensing and Business Development, AstraZeneca (UK), were examined.
Dr Richard Barker, Director General, and Mr Vincent Lawton, President, Association of the British Pharmaceutical Industry, Dr David Chiswell, Chairman, BioIndustry Association and Mr Simon Clark, Chairman, British Generic Manufacturers Association, were examined.
[Adjourned till Thursday 20 January at Ten o'clock.
Thursday 20 January 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Mr Simon Burns
Mr Jon Owen Jones | | Siobhain McDonagh
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Resolved, That the Committee do inquire into NHS Continuing Care.—(The Chairman.)
The Influence of the Pharmaceutical Industry: Professor Sir Alasdair Breckenridge CBE, Chairman, Dr June Raine, Director, Post-licensing Division, and Professor Kent Woods, Chief Executive, Medicines and Healthcare Products Regulatory Agency, were examined.
Profesor Sir Michael Rawlins, Chairman, and Andrew Dillon CBE, Chief Executive, National Institute for Clinical Excellence, were examined.
[Adjourned till Thursday 27 January at Ten o'clock.
Thursday 27 January 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr Keith Bradley
Mr Simon Burns
| | Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Draft Report (The Work of the Committee in 2004), proposed by the Chairman,
brought up and read.
Ordered, That the Chairman's draft Report be read a second time, paragraph by
paragraph.
Paragraphs 1 to 43 read and agreed to.
Resolved, That the Report be the First Report of the Committee to the House.
Ordered, That the Chairman do make the Report to the House.
New Developments in HIV/AIDS and Sexual Health Policy: Professor George Kinghorn, Consultant in Genito-urinary Medicine and Clinical Director for Communicable Diseases, Sheffield Teaching Hospitals NHS Foundation Trust, Ms Anne Weyman, Chief Executive, Family Planning Association and Dr William Ford-Young, general practitioner, Broken Cross Surgery, Macclesfield, were examined.
Ms Lisa Power, Head of Policy, Terrence Higgins Trust, Dr Max Sesay, Chief Executive Officer, African HIV Policy Network and Ms Deborah Jack, Chief Executive, National AIDS Trust were examined.
Dr David Asboe, Consultant in Genito-urinary Medicine, Chelsea and Westminster Hospital, Dr Barry Evans, Health Protection Agency, Ms Pam Ward, Co-Chair, Overseas Visitors Action Support Group and Mr Peter Nieuwets, Chair, English HIV and Sexual Health Commissioning Group, were examined.
[Adjourned till Thursday 3 February 2005 at Ten o'clock.
Thursday 3 February 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
| | Mr Jon Owen Jones
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Ordered, That Mr Chris Vellnoweth appointed a Specialist Adviser to assist the Committee in its inquiry into NHS Continuing Care.—(The Chairman.)
The Influence of the Pharmaceutical Industry: The Lord Warner, a Member of the House of Lords, Parliamentary Under-Secretary of State, Dr Felicity Harvey, Head of Medicines and Pharmacy and Industry Group and Dr June Raine, Head of Licensing Division, Medicines and Healthcare products Regulatory Agency (MHRA), were examined.
[Adjourned till Thursday 10 February 2005 at Ten o'clock.
Thursday 10 February 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
| | Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
New Developments in HIV/AIDS and Sexual Health Policy: Ms Julie Bramman, Head of Curriculum, Specialism and Collaboration, Department for Education and Skills, was examined.
Miss Melanie Johnson, a Member of the House, Parliamentary Under-Secretary of State for Public Health, Ms Elizabeth Ryan, Section Head, Injury Costs Recovery and Charging for Overseas Visitors, and Mr Geoff Dessent, Deputy Division Head, Sexual Health and Substance Misuse, Department of Health, were examined.
[Adjourned till Thursday 23 February 2005 at half past One o'clock.
Wednesday 23 February 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr David Amess
John Austin
Mr Keith Bradley
| | Mr Jon Owen Jones
Siobhain McDonagh
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Draft Report (The Prevention of Venous Thromboembolism in Hospitalised Patients), proposed by the Chairman, brought up and read.
Ordered, That the Chairman's draft Report be read a second time, paragraph by paragraph.
Paragraphs 1 to 63 read and agreed to.
Summary agreed to.
Resolved, That the Report be the Second Report of the Committee to the House.
Ordered, That the Chairman do make the Report to the House.
Ordered, That the Provisions of Standing Order No. 134 (Select Committee (Reports)) be applied to the Report.
Ordered, That the Appendices to the Minutes of Evidence taken before the Committee be reported to the House. –(The Chairman)
A Memorandum was ordered to be reported to the House.
Public Health White Paper: The Rt. Hon. Dr John Reid, a Member of the House, Secretary of State for Health, Miss Melanie Johnson, a Member of the House, Parliamentary Under-Secretary of State for Public Health and Dr Fiona Adshead, Director, Health Improvement Directorate and Deputy Chief Medical Officer, Department of Health, were examined.
[Adjourned till Thursday 3 March at Ten o'clock.
Thursday 3 March 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr David Amess
John Austin
Mr Simon Burns
| | Jim Dowd
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
The Use of Medical Technologies Within the NHS: Professor Carl May, Centre for Health Services, University of Newcastle upon Tyne; Mr Baljit Dheansa, Queen Victoria Hospital NHS Foundation Trust; Mr John Wilkinson, Association of British Healthcare Industries; Professor Sir James Underwood, President, Royal College of Pathologists; Mr Tony Rice, Tunstall Group Ltd; Dr Felicity Harvey, Professor Tom Walley and Professor Ian Philp, Department of Health; and Sir Christopher O'Donnell, Co-Chairman of the Healthcare Industries Task Force were examined.
[Adjourned till Tuesday 8 March 2005 at half past Nine o'clock.
Tuesday 8 March 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Jim Dowd
| | Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Draft Report, proposed by the Chairman, New Developments in HIV/ AIDS and Sexual Health Policy, brought up and read.
Paragraphs 1 to 177 read and agreed to.
Resolved, That the Report be the Third Report of the Committee to the House.
Ordered, That the Chairman do make the Report to the House.
Several papers were ordered to be appended to the Minutes of Evidence.
Ordered, That the provisions of Standing Order No. 116 (Select Committees (reports)) be applied to the Report.
Ordered, That the Appendices to the Minutes of Evidence taken before the Committee be reported to the House.—(The Chairman.)
A Memorandum was ordered to be reported to the House.
[Adjourned till Thursday 10 March at a quarter to Ten o'clock.
Thursday 10 March 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr David Amess
John Austin
Mr Keith Bradley
Mr Simon Burns
| | Jim Dowd
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
NHS Continuing Care: Ms Elaine McHale, Association of Directors of Social Services (ADSS), Ms Cath Attlee, Director of Commissioning & Modernisation, Hounslow Primary Care Trust, Ms Yvonne Cox, Chief Executive, Oxfordshire Learning Disability NHS Trust, Mr Michael Young, North West London Strategic Health Authority and Ms Denise Gilley, County Durham and Tees Valley Health Authority, were examined.
Ms Pauline Thompson , Policy Officer - Community Care Finance, Age Concern England, Ms Julia Cream, Head of Public Affairs and Ms Barbara Pointon, Alzheimer's Society, Mr John Wheatley, Senior Social Policy Officer (Social Exclusion, Work and Welfare) and Ms Anne Williams, Independent Complaints Advocacy Service (ICAS), Regional Co-ordinator for the North West, Citizens' Advice, were examined.
Mr John Pye, Continuing Care Nurse, RCN Member, Royal College of Nursing, Ms Louisa Stevens, Director Public Affairs, English Community Care Association, Dr Jackie Morris, Deputy Chair, Policy Committee, British Geriatrics Society and Ms Jo Peck, Head of Nursing and Clinical Governance, Medicine Division, University Hospital Lewisham NHS Trust, were examined.
[Adjourned till Tuesday 15 March 2005 at half past Nine o'clock.
Tuesday 15 March 2005
Members present:
Mr David Hinchliffe, in the Chair
John Austin
Mr Keith Bradley
Jim Dowd
| | Mr Jon Owen Jones
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
[Adjourned till Thursday 17 March at Ten o'clock.
Thursday 17 March 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr David Amess
John Austin
Mr Keith Bradley
Mr Simon Burns
| | Jim Dowd
Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
NHS Continuing Care: Ms Trish Longdon, Deputy Ombudsman and Mr Colin Houghton, Head of Continuing Care Team, The Parliamentary and Health Service Ombudsman, were examined.
Dr Stephen Ladyman MP, Minister of State for Community Care, Mr Craig Muir, Deputy Director, Care Services Directorate and Mrs Anne McDonald, Head of Delivery Programme, Older People and Disability Division, Department of Health, were examined.
[Adjourned till Tuesday 22 March 2005 at half past Nine o'clock.
Tuesday 22 March 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr Keith Bradley
Jim Dowd
Mr Jon Owen Jones | | Dr Doug Naysmith
Dr Richard Taylor |
The Committee deliberated.
Draft Report (The Influence of the Pharmaceutical Industry), proposed by the Chairman, brought up and read.
Paragraphs 1 to 392 read and agreed to.
Summary agreed to.
Text in boxes agreed to.
Annex agreed to.
Resolved, that the Report be the Fourth Report of the Committee to the House.
Ordered, That the Chairman do make the Report to the House.
Several papers were ordered to be appended to the Minutes of Evidence.
Ordered, That the Provisions of Standing Order No. 116 (Select Committees (reports)) be applied to the Report.
Ordered, That the Appendices to the Minutes of Evidence taken before the Committee be reported to the House.—(The Chairman.)
Several Memoranda were ordered to be reported to the House.
[Adjourned till Tuesday 5 April at 10.00am.
Tuesday 5 April 2005
Members present:
Mr David Hinchliffe, in the Chair
Mr Keith Bradley
Dr Doug Naysmith | | Dr Richard Taylor |
The Committee deliberated.
Draft Report (The Use of New Medical Technologies within the NHS), proposed by the Chairman, brought up and read.
Ordered, That the Chairman's draft Report be read a second time, paragraph by paragraph.
Paragraph 1 to 61 read and agreed to.
Summary agreed to.
Resolved, That the Report be the Fifth Report of the Committee to the House.
Ordered, That the Chairman do make the report to the House.
Ordered, That the Provisions of Standing Order No. 134 (Select Committee (Reports)) be applied to the Report.
Ordered, That the Appendices to the Minutes of Evidence taken before the Committee be reported to the House.
Draft Report (NHS Continuing Care), proposed by the Chairman, brought up and read.
Ordered, That the Chairman's draft Report be read a second time, paragraph by paragraph.
Paragraph 1 to 191 read and agreed to.
Summary agreed to.
Resolved, That the Report be the Sixth Report of the Committee to the House.
Ordered, That the Chairman do make the report to the House.
Ordered, That the Provisions of Standing Order No. 134 (Select Committee (Reports)) be applied to the Report.
Ordered, That the Appendices to the Minutes of Evidence taken before the Committee be reported to the House.
The Committee adjourned.
| 
